- Exhibit & Support
- Hotel & Travel
Buprenorphine is an evidence-based therapy used in medication-assisted treatment (MAT) for opioid use disorder (OUD). Many barriers exist to expanding patient access to buprenorphine, including communication among practitioners, stigma, coverage, and awareness. This session, conducted in collaboration with the American Society of Addiction Medicine, will pair a physician specialist with a pharmacist to provide an overview of buprenorphine for MAT and apply those learnings to case studies where the patient has multiple red flags and the pharmacist must decide what to do next.
At the completion of this application-based activity, participants will be able to:
Cosponsored by American Society of Addiction Medicine.